Fandy, Tamer E <br/><br/>
Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.  [electronic resource] 

 -  Molecular cancer  Jun 2008 
 - 60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-7-60  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Breast Neoplasms--genetics<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Collagen Type XI--metabolism<br/>Drug Resistance, Neoplasm--drug effects<br/>Enzyme Activation--drug effects<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Mitochondrial Proteins--genetics<br/>Photosensitizing Agents--pharmacology<br/>Protein Binding<br/>TNF-Related Apoptosis-Inducing Ligand--metabolism